Thomas Jefferson University

Jefferson Digital Commons
Phase 1

Class of 2021

2-2019

Clinical and Pathologic Factors In Breast Cancer Patients with
Bone Metastases Undergoing Surgery for Pathologic and
Impending Fractures
Emily Bochner
Thomas Jefferson University

Kerith Wang
Thomas Jefferson University

Benjamin Leiby
Thomas Jefferson University

Ayako Miura
Thomas Jefferson University

William Kevin Kelly
Thomas Jefferson University
Follow this and additional works at: https://jdc.jefferson.edu/si_ctr_2021_phase1
Part of the Oncology Commons

Let us know how access to this document benefits you
Recommended Citation
Bochner, Emily; Wang, Kerith; Leiby, Benjamin; Miura, Ayako; and Kelly, William Kevin, "Clinical and
Pathologic Factors In Breast Cancer Patients with Bone Metastases Undergoing Surgery for Pathologic
and Impending Fractures" (2019). SKMC JeffMD Scholarly Inquiry, Phase 1, Project 1.

This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Phase 1 by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.

Emily Bochner
SKMC Class of 2021
SI Abstract - CTR
December 15th, 2018
Clinical and Pathologic Factors in Breast Cancer Patients with Bone Metastases Undergoing
Surgery for Pathologic and Impending Fractures
Emily Bochner, Dr. Wm. Kevin Kelly, Kerith Wang, Benjamin Leiby, and Ayako Miura

Introduction: Metastatic lesions to bone carry a poor prognosis. Bone lesions can be responsible
for significant morbidity in patients, including pathologic or impending fractures that may
require emergent surgical evaluation.

Objective: We evaluated the clinical and pathologic features associated with breast cancer
patients with bone metastases who underwent surgery for pathologic or impending fractures.

Methods: A retrospective chart review of 20 breast cancer patients with bone metastases who
underwent surgery from the Bone Biorepository Bank at Sidney Kimmel Cancer Center was
performed. We evaluated their clinical and pathologic characteristics and performed Fisher’s
Exact Testing to explore potential associations.

Results: 90% and 15% of patients received systemic chemotherapy and bone directed radiation
prior to surgery, respectively. The average time between diagnosis to surgery was 6.21 years and
the average patient age was 63 years. 60% of the tumor specimens demonstrated medium or high

tumor burden. Similarly, 70% of the tumor specimens demonstrated a medium or high stromal
proliferative response. On Fisher’s Exact Test, while both stromal proliferative response and
tumor burden trended towards an association, this was not found to be statistically significant.

Discussion: Breast cancer patients undergoing surgery for boney metastasis were noted to have a
wide range of ages and time from diagnosis to surgery. While there was a higher percentage of
patients with tumors of high and medium tumor burden and stromal proliferative response, this
trend was not found to be statistically significant. Future studies with larger sample sizes are
required to determine the relationship between these features.

